Abstract
Background

23
Human papillomaviruses are the most important causative agents for invasive cervical cancer 24 development. HPV type-specific vaccination and HPV cervical cancer screening methods are 25 being widely recommended to control the disease but the epidemiology of the circulating 26 HPV types may vary locally. The circulating HPV-strains have never been assessed in Burundi. 27 This study determined the prevalence and genotype-specific distribution of HPV in four 28 different strata in Burundi: HIV-infected or non-infected and women living in rural or urban 29 areas. Implications for HPV diagnosis and vaccine implementation was discussed.
30
Methods
31
Four cross-sectional surveys were conducted in Burundi (2013 in a rural area and 2016 in 32 urban area) among rural and urban HIV-infected and uninfected women. Cytology and HPV 33 genotyping was performed to screen women for cervical cancer lesions. Risk factors for HPV 34 infection and cervical cancer lesions were determined using logistic regression model.
35
Results
36
HPV prevalence was very high in urban area with significant differences between HIV-positive 37 and negative women (p<0.0001). In fact, 45 .7% of HIV-positive participants were infected 38 with any HPV type and all were infected with at least one HR/pHR-HPV type. Among the HIV-39 negative participants, 13.4% were HPV-infected, of whom, only 4 women (2.7%) were 40 infected with HR/pHR-HPV types. In rural, HPV infection did not significantly differ between 41 HIV-positive and negative women (30.0% and 31.3% respectively; p=0.80). due to insufficient coverage, missed follow-up doses, strain incompatibility and cost. Indeed, 108 it remains challenging to guarantee sufficient coverage and ensure all girls of appropriate age 109 to be vaccinated. Apart from report on cross-protection [26] , the bivalent vaccine chosen by 110 Burundi offers protection against the two most prevalent HR-HPV types 16 determine adjusted odds ratios (AORs) with their 95% CIs. Analysis was conducted using 232 EpiInfo 3.5.4 software and α-error margin of 5% was considered significant. HPV 58 (2%). The most frequent pHR-HPV types were HPV 66 (4.7%) and HPV 70 (3.3%).
278
Among the LR-HPV types, the most frequently isolated were HPV 11 (15.3%) and HPV 6 (2%).
279
In the HIV-negative group, the most frequent HR-HPV types isolated were HPV 16 (4.7%), 280 followed by HPV 18 (2%). The most frequent pHR-HPV types were HPV 66 (4%) and HPV 67 281 (1.3%). The most frequent LR-HPV types were HPV 11 (20%) and HPV 6 (4%). there was no significant contributor identified, after having controlled for other covariates 349 (age, lifetime number of sex partners, profession, parity and marital status). 100% of all HSIL/ASC-H/ICC among HIV-positives and negatives respectively (Table 2) . 470 We are aware, however, of the described cross-protection [45] 
